Data as of Aug 28
| -0.11 / -1.60%|
The 4 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 8.50, with a high estimate of 12.00 and a low estimate of 7.00. The median estimate represents a +25.74% increase from the last price of 6.76.
The current consensus among 4 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.